Table 1 Patient baseline characteristics and perioperative findings.
From: Sarcopenia worsens overall survival following robotic esophagectomy for esophageal cancer
All patients | Non-Sarcopenia | Sarcopenia | p-value | ||
|---|---|---|---|---|---|
n = 204 | n = 36 (18%) | n = 168 (82%) | |||
Sex | 0.0469 | * | |||
Male | 171 (84%) | 26 (72%) | 145 (86%) | ||
Female | 33 (16%) | 10 (28%) | 23 (14%) | ||
Age (mean in years, range) | 64.5 (29.2–89.1) | 60.7 (39.5–79.9) | 65.3 (29.2–89.1) | 0.0115 | * |
BMI (mean in kg/m2, range) | 26.6 (13.7–42.4) | 31.4 (21–42.4) | 25.5 (13.7–41.9) | < 0.0001 | **** |
SMI (cm2/m2, range) | 43.1 (24.1–71) | 54.4 (39.1–71) | 40.7 (24.1–52.3) | < 0.0001 | **** |
ASA-Score | 0.6109 | ns | |||
1 | 5 (2%) | 0 | 5 (3%) | ||
2 | 109 (53%) | 23 (64%) | 86 (51%) | ||
3 | 88 (43%) | 13 (36%) | 75 (45%) | ||
4 | 2 (1%) | 0 | 2 (1%) | ||
Preoperative findings | |||||
Histology | 0.4605 | ns | |||
Adenocarcinoma | 170 (83%) | 32 (89%) | 138 (82%) | ||
Squamous cell carcinoma | 34 (17%) | 4 (11%) | 30 (18%) | ||
Tumour location | 0.699 | ns | |||
Upper | 2 (1%) | 0 | 2 (1%) | ||
Middle | 22 (11%) | 5 (14%) | 17 (10%) | ||
Lower + junction (AEG I/II) | 180 (88%) | 31 (86%) | 149 (89%) | ||
uT | 0.1621 | ns | |||
uT0 | 1 (0%) | 0 | 1 (1%) | ||
uT1 | 25 (12%) | 8 (22%) | 17 (10%) | ||
uT2 | 39 (19%) | 9 (25%) | 30 (18%) | ||
uT3 | 134 (66%) | 19 (53%) | 115 (68%) | ||
uT4 | 4 (2%) | 0 | 4 (2%) | ||
missing | 1 (0%) | 0 | 1 (1%) | ||
uN | 0.9733 | ns | |||
Negative | 63 (31%) | 11 (31%) | 52 (31%) | ||
Positive | 109 (53%) | 19 (53%) | 90 (54%) | ||
x | 31 (15%) | 6 (17%) | 25 (15%) | ||
Missing | 1 (0%) | 0 | 1 (1%) | ||
Neoadjuvant therapy | 0.1501 | ns | |||
None | 24 (12%) | 7 (19%) | 17 (10%) | ||
Yes | 180 (88%) | 29 (81%) | 151 (90%) | ||
Chemotherapy | 64 (36%) | 15 (52%) | 49 (32%) | ||
Radiochemotherapy | 115 (64%) | 14 (48%) | 102 (68%) | ||
Stricture/Dysphagia after completion of n(R)CTX | 135 (66%) | 16 (44%) | 119 (71%) | 0.0035 | ** |
Jejunal feeding tube | 0.3304 | ns | |||
Yes | 67 (33%) | 9 (25%) | 58 (35%) | ||
No | 137 (67%) | 27 (75%) | 110 (65%) | ||
Surgical approach/RAMIE | 0.6093 | ns | |||
Ivor-Lewis | 197 (97%) | 34 (94%) | 163 (97%) | ||
McKeown | 7 (3%) | 2 (6%) | 5 (3%) | ||
